A NEW BIOMEDICAL ERA IS AT HAND
Insights into Endo-Cannabinoid biology, alongside health data and ‘front-line’ lore, are driving a therapeutic revolution. The AMA now advocates for down-scheduling, NIDA and the VA are shifting stances. Research hubs are forming: UCLA, UC Irvine, UBC, Colorado State, Humboldt State, and more. States are funding their own studies. Cannabis brands are hiring MDs and PhDs, doing in-house science, and supporting university programs. Metabolic targets, formulations, treatment regimes and methods of delivery are all simultaneously exploding.
The inaugural Cannabinoid Therapeutics Symposium represents a status report from world-class biomedical researchers. This unique symposium highlights the cutting-edge of cannabis and ECS-based medicine, with a focus on the opioids-pain-cannabis nexus on Day One, while Day Two presents institutional reports and funding discussions. Participating hospitals, med schools, specialist associations, biomedical PIs, clinicians, internists, health officials, insurers, R&D scouts from pharma/biotech, cosmetics, and nutraceuticals, as well as Chief Scientists and Chief Medical Officers from “cannaceutical” developers, will share insights and collaborative projects. In addition, state regulators from the co-located CannaWEST Compliance Summit will join to understand implications for future policy-making. This Symposium is a must-attend event for all serious stakeholders in cannabis and cannabinoid-based medicine.
Interested in Sponsoring? For Sponsorship Opportunities:
Contact Maggie Trigueros | [email protected]
818-888-4445 ext 55
Interested in Speaking? For Speaking Opportunities:
Contact Erin Dolleris | [email protected]
818-888-4445 ext 48
Roger G. Pertwee, MA,
DPhil, DSc, HonFBPhS
Medical Sciences and Nutrition,
Institute of Medical Sciences,
UNIVERSITY OF ABERDEEN;
Director of Pharmacology,
GW PHARMACEUTICALS
Daniele Piomelli, PhD, MD (h.c.)
Director, UCI Institute for the Study of Cannabis; Louise Turner Arnold Chair in the Neurosciences,
Professor of Anatomy and
Neurobiology, Pharmacology and Biological Chemistry,
UC IRVINE
Tom Arneson, MD, MPH
Research Manager, Office of Medical Cannabis
MINNESOTA DEPARTMENT OF HEALTH
Laura Borgelt, PharmD, FCCP, BCPS
Associate Dean of Administration and Operations and Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences
UNIVERSITY OF COLORADO ANSCHUTZ MEDICAL CAMPUS
Barbara A. Brett, PhD
Associate Professor, Department of Psychology
COLORADO STATE UNIVERSITY – PUEBLO
Ziva Cooper, PhD
Associate Professor of Clinical Neurobiology (in Psychiatry)
COLUMBIA UNIVERSITY MEDICAL CENTER
Chris Evans, PhD
Director, Hatos Center for Neuropharmacology in the Semel Institute
UCLA
Timothy Fong, MD
Professor of Psychiatry; Director; Faculty
UCLA; UCLA ADDICTION PSYCHIATRY FELLOWSHIP; UCLA CANNABIS RESEARCH INITIATIVE
Ken Gershman, MD, MPH
Manager, Medical Marijuana Grants Program
COLORADO DEPARTMENT OF PUBLIC HEALTH & ENVIRONMENT
Bonni Goldstein, MD
Medical Director
CANNA-CENTERS
Jeffrey Hergenrather, MD
Executive Director
SOCIETY FOR CANNABIS CLINICIANS
Sean McAllister, MD
Scientist - California Pacific Medical Center Research Institute
SUTTER HEALTH
Mitzi Nagarkatti
SmartState Endowed Chair of Center for Cancer Drug Discovery, Carolina Distinguished Professor, Chair, Dept. of Pathology, Microbiology and Immunology, School of Medicine
UNIVERSITY OF SOUTH CAROLINA
Prakash Nagarkatti, PhD
Vice President for Research, and Director, NIH Center for CAM Research on Autoimmune and Inflammatory Diseases
UNIVERSITY OF SOUTH CAROLINA
Laura Packel, Ph.D., M.P.H.
Program Officer for Clinical Sciences and Epidemiology, Tobacco-related Disease Research Program, Research Grants Program Office
UNIVERSITY OF CALIFORNIA, OFFICE OF THE PRESIDENT
Roger G. Pertwee, MA, DPhil, DSc, HonFBPhS
Emeritus Professor, School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences; Director of Pharmacology
UNIVERSITY OF ABERDEEN; GW PHARMACEUTICALS
Joseph M. Pierre, MD
Associate Director of Residency Education; Health Sciences Clinical Professor, Department of Psychiatry & Biobehavioral Sciences; Acting Chief, Hospital Psychiatry Divisions,;
UCLA SEMEL INSTITUTE FOR NEUROSCIENCE & WEST LOS ANGELES VA MEDICAL CENTER; DAVID GEFFEN SCHOOL OF MEDICINE AT UCLA; WEST LOS ANGELES VA MEDICAL CENTER
Daniele Piomelli, PhD, MD (h.c.)
Director, UCI’s Center for the Study of Cannabis; Louise Turner Arnold Chair in the Neurosciences, Professor of Anatomy and Neurobiology, Pharmacology and Biological Chemistry
UC IRVINE
Sue Sisley, MD
PI, Cannabis for Veterans PTSD Study; PI, Cannabis and Pain Study; President
UNIVERSITY OF MICHIGAN IRB; SCOTTSDALE RESEARCH INSTITUTE
Chairman Sponsor
Partner Sponsor
Silver Sponsor
To learn more about sponsorship benefits, please contact Maggie Trigueros at [email protected] or call 818-888-4445 ext 55
Crowne Plaza Redondo Beach & Marina Hotel
300 N. Harbor Drive
Redondo Beach, CA 90277
(310) 318-8888
Room rate: $199
Reservation Call-in #: (310) 318-8888
Cutoff Date: Tuesday, May 15, 2018
Group Name: Infocast
Group Code: CW6
Group Online Booking Link: Infocast